Steph Sherer, Founder and President of Americans for Safe Access (ASA), discusses the prevalence, challenges and treatments for chronic pain management.
BioBloom has specialised in the production of high-quality organic hemp products with absolutely no additives since 2016. The production focuses on the preservation of all valuable ingredients of the hemp plant.
Professor Mike Barnes, Director of Education at The Academy of Medical Cannabis shares his thoughts on the rescheduling of cannabis to a Schedule II substance in November of 2018 and access to medical cannabis prescriptions.
Canna CBD Limited chart the impact of cannabidiol on mainstream fast-moving consumer goods, adopting custom from other lifestyle categories, such as alcohol, tobacco/vaping, cosmetics and health foods.
AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.
As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.
A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.
Here, we find out about Fundación CANNA’s aim is to promote research and education about cannabis, including their strong focus on the effects of this on the human body.
GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.
Whether you see it as the “latest” health craze, have considered taking it yourself, or, have been relying on it for some time now, you may have asked: Can someone take too much CBD? Here, we find out.
